Assay and Screen Development

We design bespoke product assays, combining classical techniques with cutting-edge synthetic biology to precisely monitor biomolecule production. These provide a simple, reliable and practical means to identify top-performing production strains from libraries of variants and include:

“The process efficiency gains Ingenza delivered were transformational in progressing our lead compound from feasibility to clinical testing.”

— Dr Gordon Barker, CEO, Amprologix Ltd

  • ultra-high throughput colorimetric/fluorometric detection
  • media or growth-based selection schemes
  • selection for resistance to toxic analogues of target products
  • use of customised, easily removable, biomarker tags

Want to Know More?

We’d love to hear from you.